Rezpio
Respiratory monitoring under CE MDR Class IIa
Rezpio is the medical device track of the platform, under CE MDR Class IIa certification for home and clinical use in asthma and COPD. It pairs voice derived respiratory markers with a clinician facing studio, patient app and the governance, risk and post market surveillance framework required by MDR.
Class IIa
Classification
CE MDR
Framework
Asthma · COPD
Indications
What you get
Asthma & COPD
Monitoring pathways aligned to GINA and GOLD staging.
Home and clinic
Patient app for daily checks, clinician studio for review and escalation.
MDR framework
Risk management, clinical evaluation and post market surveillance under ISO 13485.
Clinician workflow
Trends, alerts and reports designed around respiratory follow up.
Under CE MDR Class IIa certification. Voice derived estimates.
Talk to us about Rezpio
A short form is enough. We will come back with a walkthrough, trial access where it applies, and pricing for your volumes.
Visit the Rezpio websiteBook a demo or start a free trial
Tell us a little about your use case. We reply within one business day.
